SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is at the center of intense debate following a cryptic social media post from its CEO regarding balance sheet strengthening and global expansion, fueling speculation about potential non-dilutive capital or strategic partnerships. While some investors fear further dilution, the community is largely focused on upcoming international expansion milestones and potential government-backed funding, viewing the current volatility as a battleground between persistent short-selling pressure and long-term bullish conviction in the company's clinical pipeline.

Spdr Dow Jones Industrial Average ETF Trust - Units of undivided interest in DIAMONDS Trust Series 1

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market volatility as investors weigh conflicting reports over the potential resolution of the U.S. military campaign in Iran. While some traders are reacting to speculative optimism regarding a diplomatic wind-down, the community remains deeply divided, with many debating the impact of energy supply disruptions and the sustainability of market rallies amidst persistent geopolitical uncertainty.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is rallying in after-hours trading following reports that the U.S. is prepared to conclude military operations against Iran even if the Strait of Hormuz remains closed. While the news sparked an immediate surge in equity futures and a cooling in oil prices, the community remains deeply divided, with many traders debating whether this is a genuine de-escalation or a tactical 'pump and dump' setup ahead of potential further conflict.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy ($MULN) is trending as the community debates the token's legitimacy, with supporters promoting it as a community-driven movement with utility while critics label it a scam linked to the previous EV stock volatility. Discussions remain highly polarized, centering on accusations of market manipulation and pump-and-dump tactics versus retail-led attempts to build a long-term decentralized project.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing significant downward pressure as it navigates a broader tech sector sell-off and investor apprehension regarding geopolitical instability in the Middle East. While retail sentiment remains deeply polarized between those betting on long-term AI-driven fundamental growth and those expecting a deeper valuation reset, the community is actively debating whether the current pullback represents a strategic buying opportunity or a signal of structural weakness.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors weigh escalating geopolitical tensions in the Middle East, specifically reports of tanker attacks and blocked shipping routes in the Strait of Hormuz, against mixed signals from U.S. leadership regarding diplomatic negotiations. The community remains deeply divided, with some traders betting on further supply-driven price surges toward historic highs, while others argue that aggressive market rhetoric is merely noise masking institutional manipulation or the potential for a sudden, policy-driven pullback.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is experiencing significant downward pressure as investors rotate out of AI-linked semiconductor stocks following reports of Googles new memory-compression algorithm, TurboQuant, which fueled concerns about future demand for memory chips. The community remains deeply divided, with some investors panic-selling into a deepening technical breakdown while others aggressively argue the stock is a long-term value play, pointing to historical earnings strength and arguing that current volatility is driven by macro-headwinds and market manipulation rather than fundamental flaws.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is currently trending due to active investor focus on potential margin risks surrounding upcoming shareholder votes on ESG-related proposals, alongside broader market debates regarding the sustainability of its high-margin service business amidst geopolitical and defense-sector volatility. The community remains closely divided, balancing bullish optimism regarding the company's recurring revenue moat and defense backlog against concerns over governance uncertainties and recent technical price weakness.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the focus of investor attention due to the rare and significant move by CEO Peter Beck to waive his salary and bonuses, which the community interprets as a strong long-term commitment to shareholder value. This development, coupled with regulatory approval for the acquisition of Mynaric and a robust backlog of government contracts, has fueled discussions around the companys potential as a long-term growth play in the aerospace sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.

Satsuma Pharmaceuticals Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

STSA
Satsuma Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STSA News

STSASatsuma Pharmaceuticals Inc